Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 20;39(1):114-121.
doi: 10.1093/ndt/gfad120.

Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function

David Cucchiari  1   2 , Elena Cuadrado-Payan  1   2 , Eva Gonzalez-Roca  3 , Ignacio Revuelta  1   2   4 , Maria Argudo  1 , Maria José Ramirez-Bajo  2   4 , Pedro Ventura-Aguiar  1   2 , Jordi Rovira  2   4 , Elisenda Bañon-Maneus  2   4 , Enrique Montagud-Marrahi  1 , Diana Rodriguez-Espinosa  1 , Judit Cacho  1 , Carolt Arana  1 , Vicens Torregrosa  1 , Nuria Esforzado  1 , Frederic Cofàn  1 , Frederic Oppenheimer  1   2   4 , Mireia Musquera  5 , Lluís Peri  5 , Silvia Casas  6 , Sham Dholakia  6 , Eduard Palou  7 , Josep M Campistol  1   2   4 , Beatriu Bayés  1   2 , Joan Anton Puig  3 , Fritz Diekmann  1   2   4
Affiliations

Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function

David Cucchiari et al. Nephrol Dial Transplant. .

Abstract

Background: Ischemia-reperfusion injury (IRI) upon transplantation is one of the most impactful events that the kidney graft suffers during its life. Its clinical manifestation in the recipient, delayed graft function (DGF), has serious prognostic consequences. However, the different definitions of DGF are subject to physicians' choices and centers' policies, and a more objective tool to quantify IRI is needed. Here, we propose the use of donor-derived cell-free DNA (ddcfDNA) for this scope.

Methods: ddcfDNA was assessed in 61 kidney transplant recipients of either living or deceased donors at 24 h, and 7, 14 and 30 days after transplantation using the AlloSeq cfDNA Kit (CareDx, San Francisco, CA, USA). Patients were followed-up for 6 months and 7-year graft survival was estimated through the complete and functional iBox tool.

Results: Twenty-four-hour ddcfDNA was associated with functional DGF [7.20% (2.35%-15.50%) in patients with functional DGF versus 2.70% (1.55%-4.05%) in patients without it, P = .023] and 6-month estimated glomerular filtration rate (r = -0.311, P = .023). At Day 7 after transplantation, ddcfDNA was associated with dialysis duration in DGF patients (r = 0.612, P = .005) and worse 7-year iBox-estimated graft survival probability (β -0.42, P = .001) at multivariable analysis. Patients with early normalization of ddcfDNA (<0.5% at 1 week) had improved functional iBox-estimated probability of graft survival (79.5 ± 16.8%) in comparison with patients with 7-day ddcfDNA ≥0.5% (67.7 ± 24.1%) (P = .047).

Conclusions: ddcfDNA early kinetics after transplantation reflect recovery from IRI and are associated with short-, medium- and long-term graft outcome. This may provide a more objective estimate of IRI severity in comparison with the clinical-based definitions of DGF.

Keywords: biomarkers; ddcfDNA; delayed graft function; ischemia–reperfusion injury; kidney transplantation.

PubMed Disclaimer

References

Publication types

Substances

Grants and funding